(19)
(11) EP 1 183 391 A2

(12)

(88) Date of publication A3:
15.03.2001

(43) Date of publication:
06.03.2002 Bulletin 2002/10

(21) Application number: 00937642.7

(22) Date of filing: 20.05.2000
(51) International Patent Classification (IPC)7C12Q 1/68, G01N 33/53, C07K 1/00, A61K 38/00
(86) International application number:
PCT/US0013/961
(87) International publication number:
WO 0071/080 (30.11.2000 Gazette 2000/48)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 20.05.1999 US 135035 P

(71) Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Salt Lake City, Utah 84112 (US)

(72) Inventors:
  • Bolger, Graeme B.
    Salt Lake City, UT 84103 (US)
  • Houslay, Miles D.,Pharm. Group, Dvn. of Bioch.
    Glasgow G12 8QQ (GB)
  • Steele, Michael R.
    Salt Lake City, UT 84105 (US)
  • Yarwood, Stephen J.,Ontario Canc. Inst. Res. Dep
    Toronto,Ontario (CA)

(74) Representative: Wakerley, Helen Rachael et al
Reddie & Grose, 16 Theobalds Road
London WC1X 8PL
London WC1X 8PL (GB)

   


(54) INTERACTION OF THE CYCLIC-AMP-SPECIFIC PHOSPHODIESTERASE PDE4D5 WITH RACK1